HOME › DRUGS › TRAMETINIB
ACTIVE SUBSTANCE / INN

TRAMETINIB

Brand name(s): MEKINIST, Mekinist, Spexotras
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Glioma
Melanoma
ACTIVE SUBSTANCE
Trametinib
REGULATORS
FDA · EMA
SPONSORS / MAH
NOVARTIS, Novartis Europharm Limited
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
MEKINISTNDA217513NOVARTISPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
MekinistNovartis Europharm LimitedAuthorised30/06/2014Melanoma
SpexotrasNovartis Europharm LimitedAuthorised05/01/2024Glioma

FULL INTELLIGENCE ON TRAMETINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →